Abstract

15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) is one of factors contributed to the neurotoxicity of amyloid β (Aβ), a causative protein of Alzheimer's disease. Type 2 receptor for prostaglandin D2 (DP2) and peroxysome-proliferator activated receptorγ (PPARγ) are identified as the membrane receptor and the nuclear receptor for 15d-PGJ2, respectively. Previously, we reported that the cytotoxicity of 15d-PGJ2 was independent of DP2 and PPARγ, and suggested that 15d-PGJ2 induced apoptosis through the novel specific binding sites of 15d-PGJ2 different from DP2 and PPARγ. To relate the cytotoxicity of 15d-PGJ2 to amyloidoses, we performed binding assay [3H]15d-PGJ2 and specified targets for 15d-PGJ2 associated with cytotoxicity. In the various cell lines, there was a close correlation between the susceptibilities to 15d-PGJ2 and fibrillar Aβ. Specific binding sites of [3H]15d-PGJ2 were detected in rat cortical neurons and human bronchial smooth muscle cells. When the binding assay was performed in subcellular fractions of neurons, the specific binding sites of [3H]15d-PGJ2 were detected in plasma membrane, nuclear and cytosol, but not in microsome. A proteomic approach was used to identify protein targets for 15d-PGJ2 in the plasma membrane. By using biotinylated 15d-PGJ2, eleven proteins were identified as biotin-positive spots and classified into three different functional proteins: glycolytic enzymes (Enolase2, pyruvate kinase M1 (PKM1) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)), molecular chaperones (heat shock protein 8 and T-complex protein 1 subunit α), cytoskeletal proteins (Actin β, F-actin-capping protein, Tubulin β and Internexin α). GAPDH, PKM1 and Tubulin β are Aβ-interacting proteins. Thus, the present study suggested that 15d-PGJ2 plays an important role in amyloidoses not only in the central nervous system but also in the peripheral tissues.

Highlights

  • Eicosanoids are divided into two groups, according to their mechanism of action: the conventional eicosanoids, e.g., prostaglandin D2 (PGD2) and the cyclopentenone-type PGs, e.g., 15-deoxyD12,14-prostaglandin J2 (PGJ2) (15d-PGJ2)

  • bronchial smooth muscle cells (BSMC), hepatocytes and dermal fibroblasts were exposed to fAb or vehicle for 48 h, and their viability was quantified by the MTT-reducing activity

  • The specific binding sites of [3H]15d-PGJ2 were detected in the neuronal subcellular fractions of nuclear, cytosol and plasma membrane, but not in the microsomal fraction. 15dPGJ2 binds to the nuclear receptor, peroxysome-proliferator activated receptorc (PPARc) [9] and the cytosolic protein, Ras [23]

Read more

Summary

Introduction

Eicosanoids are divided into two groups, according to their mechanism of action: the conventional eicosanoids, e.g., prostaglandin D2 (PGD2) and the cyclopentenone-type PGs, e.g., 15-deoxyD12,14-PGJ2 (15d-PGJ2). Amyloid b (Ab) generated PGD2 from cortical neurons before inflammation [3]. The toxicity of PGD2 via its GTP-binding protein-coupled PGD2 receptors does not occur. Little mRNA of the PGD2 receptor is observed in the rat [5] and human [6] cerebral cortex. Few binding sites of [3H]PGD2 were detected in the plasma membranes from rat cortices [4]. The extent of specific [3H]PGD2 in total biding is much lower (30–40%) than that of [3H]15d-PGJ2 (.80%), binding sites of PGD2 have been reported in synaptosomes of rat [7] and human brains [6]. PGD2 appeared to mediate inflammation via 15d-PGJ2 in the amyloidoses

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call